Cancer
Cancer Ongoing 2019 Newcastle NSW, Murdoch WA

POSNOC

To assess whether adjuvant therapy alone is no worse than adjuvant therapy plus axillary treatment, in terms of axillary recurrence within 5 years.

Trial overview

Disease
Breast cancer
Topic
POSNOC
Eligibility criteria

To be considered for the study you must meet the following criteria:

  • 50 years of age or older
  • Have histologically confirmed breast cancer
  • Nodal involvement
Study details

The study will compare adjuvant therapy alone with adjuvant therapy plus axillary treatment (axillary node clearance (ANC) or axillary radiotherapy (ART)).

Your participation in this study will be for approximately 5 years.

Sign up to this clinical trial here.

Location

Newcastle NSW, Murdoch WA

Contact